{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T02:02:39Z","timestamp":1697508159475},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1046\/j.1365-2230.2001.00784.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:02:05Z","timestamp":1047376925000},"page":"155-161","source":"Crossref","is-referenced-by-count":7,"title":["Peroxisomal proliferator-activated ligand therapy for HIV lipodystrophy"],"prefix":"10.1093","volume":"26","author":[{"given":"K. J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. G.","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB1|cit1","first-page":"1332","article-title":"Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting","volume":"82","author":"Grinspoon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00042560-199903010-00003","article-title":"Studies of body composition and fat distribution in HIV-infected and control subjects","volume":"20","author":"Kotler","year":"1999","journal-title":"J Acquir Immune Def Syndr Hum Retrovirol"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s000180050192","article-title":"The role of peroxisomes in aging","volume":"54","author":"Perichon","year":"1998","journal-title":"Cell Mol Life Sci"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB4|cit4","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/jnci\/90.22.1702","article-title":"Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha","volume":"90","author":"Gonzales","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0098-2997(98)00003-X","article-title":"Lipid metabolism in peroxisomes in relation to human disease","volume":"19","author":"Wanders","year":"1998","journal-title":"Mol Aspects Med"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1006863123068","article-title":"On the role of the peroxiome in cell differentiation and carcinogenesis","volume":"187","author":"Masters","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB7|cit7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/s0006-2952(98)00116-6","article-title":"On the role of the peroxisome in the metabolism of drugs and xenobiotics","volume":"56","author":"Masters","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB8|cit8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/s0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviraltherapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB9|cit9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0140-6736(98)10364-1","article-title":"Medical significance of peroxiome proliferator actived receptors","volume":"354","author":"Vainecq","year":"1999","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1006863123068","article-title":"On the role of the peroxiome in cell differentiation and carcinogenesis","volume":"187","author":"Masters","year":"1998;","journal-title":"Mol Cell Biochem"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0248-4900(05)80173-X","article-title":"Peroxisome proliferators and cellular signalling pathways: a review","volume":"77","author":"Bieri","year":"1998","journal-title":"Biol Cell"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB12|cit12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/s0531-5565(98)00014-x","article-title":"The biological significance of plasmalogens in defene against oxidative damage","volume":"33","author":"Brosche","year":"1998;","journal-title":"Exp Gerontol"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB13|cit13","first-page":"1099","article-title":"Cytokine dysregulation in AIDS. in vivo over expression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GRO","volume":"5","author":"Dexibe","year":"1992","journal-title":"J Acquir Immune Def Syndr"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0009-2797(94)90037-X","article-title":"Antioxidant status and lipid peroxidation in patients infected with HIV","volume":"91","author":"Favier","year":"1994","journal-title":"Chem Biol Interact"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0167-5699(94)90245-3","article-title":"Oxidative stress and apoptosis in HIV infection: a role for plant derived metabolites with synergistic antioxidant activity","volume":"15","author":"Greenspan","year":"1994","journal-title":"Immunol Today"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"32833","DOI":"10.1074\/jbc.273.49.32833","article-title":"Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappa B signaling, and reduces inflammatory cytokine production in aging","volume":"273","author":"Poynter","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0026-0495(98)90203-7","article-title":"Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease","volume":"47","author":"Jovinge","year":"1998","journal-title":"Metabolism"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB18|cit18","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/s0140-6736(98)03391-1","article-title":"pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.38.1.389","article-title":"In vitro and in vivo drug interactions involving human CYP3A","volume":"38","author":"Thummel","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB20|cit20","first-page":"609","article-title":"Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human innumodeficiency virus-protease inhibitor nelfinavir mesylate","volume":"26","author":"Lillibridge","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2143(96)90145-6","article-title":"Longitudinal study of adrenal steroids in a cohort of HIV-infected patients with hemophilia","volume":"127","author":"Chatterton","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3109\/00498259609050262","article-title":"Interleukin 1 beta and interleukin 6 repress clofibric acid induction of different P450 isoforms in cultured foetal rat hepatocytes","volume":"26","author":"Parmentier","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-2143(96)90141-9","article-title":"Spotlight on DHEA: A marker for progression of HIV infection?","volume":"127","author":"Brind","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB24|cit24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/s0306-4530(97)00015-2","article-title":"Serum cortisol and DHEA concentrations during HIV infection","volume":"22","author":"Christeff","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB25|cit25","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/s0306-4530(97)00019-x","article-title":"A possible role for the cortisol\/anticortisols imbalance in the progression of human immunodeficiency virus","volume":"22","author":"Clerici","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB26|cit26","first-page":"193","article-title":"Cytochrome P-450 mRNAs are modulated by dehydroepiandrosterone, nafenopm, and triiodothyronine","volume":"27","author":"Singleton","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB27|cit27","first-page":"S129","article-title":"role of metabolism in the activation of dehdroepiandrosterone as a peroxisome proliferator","volume":"150","author":"Waxinan","year":"1996","journal-title":"J Endocrinol"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB28|cit28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/(sici)1097-4644(20000101)76:1<13::aid-jcb2>3.0.co;2-t","article-title":"Glucocorticoid can resuce the transcriptional activation of HIV-1 promoter through the reduction of active N17-kappa13","volume":"76","author":"Kurata","year":"1999","journal-title":"J Cell Biochem"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB29|cit29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/088922200309412","article-title":"Occurrence of additional N17-kappaB-binding motifs in the long terminal repeat region of South African HIV type 1 subtype C isolates","volume":"16","author":"Hunt","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB30|cit30","first-page":"459","article-title":"An open-label dose-escalation trial of oral dehydroeplandrosterone tolerance and pharmacokinetics in patients with HIV disease","volume":"6","author":"Dyner","year":"1993","journal-title":"J Acquir Immunol Def Syndr"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2265.1998.00507.x","article-title":"the effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women","volume":"49","author":"Morles","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB32|cit32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s0304-3940(99)00055-5","article-title":"Activators of peroxisome proliferator-activated receptor-gamma inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells","volume":"262","author":"Kitamura","year":"1999","journal-title":"Neuroscience Lett"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB33|cit33","first-page":"715","article-title":"Cox-2, iNOS, and p53 as ply-makers of tumor antiogeneiss [Review]","volume":"2","author":"Chiartigi","year":"1998","journal-title":"Int J Mol Med"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB34|cit34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1365-2567.1998.00646.x","article-title":"Specific N17-kappa beta blockade selectively inhibits tumour necrosis factor-alpha-induced COS-2 but not constitutive COX-1 expression in HT-29 cells","volume":"95","author":"Morteau","year":"1998","journal-title":"Immunology"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s000110050284","article-title":"Anti-inflammatory drugs and their mechanism of action","volume":"47","author":"Vane","year":"1992","journal-title":"Inflam Res"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB36|cit36","first-page":"1017","article-title":"Altered production of PGE2, IL-1 beta and TNF-alpha by peripheral blood monocytes from HIV-positive individuals at early stages of HIV infection","volume":"6","author":"Longo","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/00002030-199610090-00018","article-title":"Contribution of prostaglandin E2 to the interleukin-12 defect in HIV infected patients","volume":"10","author":"Chougnet","year":"1996","journal-title":"AIDS"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.510300224","article-title":"Nonsteroidal anti-inflammatory drug metabolism potentiates interferon alfa signaling by increasing STATI phosphorylation","volume":"30","author":"Glambartolomei","year":"1999","journal-title":"Hepatology"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.7556\/jaoa.1999.99.8.S10","article-title":"NSAIDs and the gastrointestinal tract: an update on recent progress","volume":"99","author":"Silverman","year":"1999","journal-title":"J Am Osteopath Assoc"},{"key":"10.1046\/j.1365-2230.2001.00784.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO;2-V","article-title":"Basic biology and clinical application of specific cycloxygenase-2 inhibitors","volume":"43","author":"Crofford","year":"2000","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2001.00784.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2001.00784.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2230.2001.00784.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:00:26Z","timestamp":1676376026000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/26\/2\/155\/6631156"}},"subtitle":["Ligand therapy for HIV lipodystrophy"],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,3]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2230.2001.00784.x","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}